NO914541D0 - Fremgangsmaate ved fremstilling av tumor-nekrose-faktor-muteiner - Google Patents

Fremgangsmaate ved fremstilling av tumor-nekrose-faktor-muteiner

Info

Publication number
NO914541D0
NO914541D0 NO914541A NO914541A NO914541D0 NO 914541 D0 NO914541 D0 NO 914541D0 NO 914541 A NO914541 A NO 914541A NO 914541 A NO914541 A NO 914541A NO 914541 D0 NO914541 D0 NO 914541D0
Authority
NO
Norway
Prior art keywords
muteines
necrose
factor
procedure
tumor
Prior art date
Application number
NO914541A
Other languages
English (en)
Other versions
NO914541L (no
Inventor
Walter Fiers
Jan Tavernier
Xaveer Van Ostade
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO914541D0 publication Critical patent/NO914541D0/no
Publication of NO914541L publication Critical patent/NO914541L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO91914541A 1990-11-21 1991-11-20 Fremgangsmaate ved fremstilling av tumor-nekrose-faktor-muteiner NO914541L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90810901 1990-11-21

Publications (2)

Publication Number Publication Date
NO914541D0 true NO914541D0 (no) 1991-11-20
NO914541L NO914541L (no) 1992-05-22

Family

ID=8205969

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91914541A NO914541L (no) 1990-11-21 1991-11-20 Fremgangsmaate ved fremstilling av tumor-nekrose-faktor-muteiner

Country Status (17)

Country Link
US (2) US5422104A (no)
EP (1) EP0486908A3 (no)
JP (1) JPH06256395A (no)
AR (1) AR245783A1 (no)
AU (1) AU655948B2 (no)
CA (1) CA2055168A1 (no)
FI (1) FI915379A (no)
HU (1) HUT62034A (no)
IE (1) IE914035A1 (no)
IL (1) IL100062A0 (no)
MC (1) MC2300A1 (no)
MX (1) MX9102110A (no)
NO (1) NO914541L (no)
NZ (1) NZ240595A (no)
PT (1) PT99560A (no)
UY (1) UY23327A1 (no)
ZA (1) ZA919035B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK376492A3 (en) * 1992-04-02 1995-06-07 Hoffmann La Roche Tnf - muteins and method of their production
CA2119089A1 (en) * 1993-03-29 1994-09-30 David Banner Tumor necrosis factor muteins
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
EP1069917A4 (en) * 1998-03-20 2005-02-09 Genzyme Corp NEW COMPLEMENTARY PAIRS OF RECEPTORS / LIGANDS AND ADOPTIVE IMMUNOTHERAPY USING THE SAME
DE60028830T2 (de) * 2000-02-16 2007-01-18 Genentech, Inc., South San Francisco Anti-april antikörper und hybridomazellen
US20070172449A1 (en) * 2000-03-02 2007-07-26 Xencor, Inc. TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS
US7662367B2 (en) 2000-03-02 2010-02-16 Xencor, Inc. Pharmaceutical compositions for the treatment of TNF-α related disorders
US7056695B2 (en) 2000-03-02 2006-06-06 Xencor TNF-α variants
US7687461B2 (en) * 2000-03-02 2010-03-30 Xencor, Inc. Treatment of TNF-α related disorders with TNF-α variant proteins
US7446174B2 (en) 2001-03-02 2008-11-04 Xencor, Inc. Protein based TNF-α variants for the treatment of TNF-α related disorders
US7244823B2 (en) 2000-03-02 2007-07-17 Xencor TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
US7101974B2 (en) 2000-03-02 2006-09-05 Xencor TNF-αvariants
US6579522B1 (en) * 2000-06-27 2003-06-17 Genvec, Inc. Replication deficient adenoviral TNF vector
EA007984B1 (ru) * 2001-08-03 2007-02-27 Дженентек, Инк. ПОЛИПЕПТИДЫ TACIs И BR3 И ИХ ПРИМЕНЕНИЕ
US20030086903A1 (en) * 2001-11-02 2003-05-08 Genvec, Inc. Therapeutic regimen for treating cancer
US7786282B2 (en) * 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
JP2005533863A (ja) * 2002-07-25 2005-11-10 ジェネンテック・インコーポレーテッド Ｔａｃｉ抗体とその用途
ES2347239T3 (es) * 2002-12-02 2010-10-27 Amgen Fremont Inc. Anticuerpos dirigidos al factor de necrosis tumoral y usos de los mismos.
KR20060027801A (ko) * 2003-06-05 2006-03-28 제넨테크, 인크. Ｂ 세포 장애에 대한 조합 요법
US20050163775A1 (en) * 2003-06-05 2005-07-28 Genentech, Inc. Combination therapy for B cell disorders
ATE458500T1 (de) * 2003-11-14 2010-03-15 Genvec Inc Pharmazeutische verbindung zur behandlung von lokal fortgeschrittenem primär inoperablen pankreaskarzinom (lapc).
TW200526780A (en) * 2004-01-06 2005-08-16 Hayashibara Biochem Lab TNF antagonists and TNF inhibitors comprising the same as the active ingredient
EP1598075A1 (en) * 2004-05-21 2005-11-23 LEK Pharmaceuticals d.d. Process for the isolation and / or purification of proteins
GB0425972D0 (en) 2004-11-25 2004-12-29 Celltech R&D Ltd Biological products
JP2008526889A (ja) * 2005-01-10 2008-07-24 リサーチ ディベロップメント ファウンデーション 癌治療のための標的化キメラ分子
AU2006318539B2 (en) * 2005-11-23 2012-09-13 Genentech, Inc. Methods and compositions related to B cell assays
WO2008127515A1 (en) * 2007-03-01 2008-10-23 Cytologic, Inc. Compositions and method for enhancing immune responses in mammals
US11535673B2 (en) * 2007-04-05 2022-12-27 President and Fellows of Harvard CoHege Chimeric activators: quantitatively designed protein therapeutics and uses thereof
US9605844B2 (en) * 2009-09-01 2017-03-28 Cree, Inc. Lighting device with heat dissipation elements
PT2953634T (pt) 2013-02-07 2021-09-02 Massachusetts Gen Hospital Métodos de expansão ou depleção das células t reguladoras
EP3139955B1 (en) 2014-04-30 2024-03-20 President and Fellows of Harvard College Fusion proteins for treating cancer and related methods
AU2017358578B2 (en) 2016-11-09 2022-12-08 Philogen S.P.A IL2 and TNF mutant immunoconjugates
CA3193273A1 (en) 2020-08-27 2022-03-03 Enosi Therapeutics Corporation Methods and compositions to treat autoimmune diseases and cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR851626B (no) * 1984-07-05 1985-11-26 Genentech Inc
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
ATE107362T1 (de) * 1986-06-20 1994-07-15 Dainippon Pharmaceutical Co Polypeptid-mutanten des menschlichen tnf und für diese mutanten codierende dns.
JPH07106158B2 (ja) * 1986-12-04 1995-11-15 サントリー株式会社 抗腫瘍活性を有する新規ポリペプチドおよびその製造法
AU1346488A (en) * 1987-02-26 1988-09-26 Cetus Corporation Arginine-depleted human tumor necrosis factor
JPS63291590A (ja) * 1987-05-25 1988-11-29 Teijin Ltd 新規生理活性ポリペプチド
DE3843534A1 (de) * 1988-12-23 1990-07-12 Basf Ag Neue tnf-polypeptide

Also Published As

Publication number Publication date
IL100062A0 (en) 1992-08-18
ZA919035B (en) 1992-08-26
EP0486908A3 (en) 1992-11-19
IE914035A1 (en) 1992-06-03
HUT62034A (en) 1993-03-29
NZ240595A (en) 1994-09-27
MC2300A1 (fr) 1993-09-06
MX9102110A (es) 1992-07-08
AU8791591A (en) 1992-05-28
NO914541L (no) 1992-05-22
AR245783A1 (es) 1994-02-28
FI915379A (fi) 1992-05-22
PT99560A (pt) 1992-10-30
UY23327A1 (es) 1992-05-19
AU655948B2 (en) 1995-01-19
CA2055168A1 (en) 1992-05-22
US5422104A (en) 1995-06-06
HU913595D0 (en) 1992-01-28
US5652353A (en) 1997-07-29
JPH06256395A (ja) 1994-09-13
EP0486908A2 (en) 1992-05-27
FI915379A0 (fi) 1991-11-14

Similar Documents

Publication Publication Date Title
NO914541D0 (no) Fremgangsmaate ved fremstilling av tumor-nekrose-faktor-muteiner
NO920108D0 (no) Fremgangsmaate ved fremstilling av celluloseholdige legemer
FI923931A (fi) Anordning foer granskning av insidan av en foergrenad roerlinje
NO920105L (no) Fremgangsmaate ved fremstilling av cellluloseholdige legemer
NO914666D0 (no) Fjerning av trialkylassiner
NO910848D0 (no) Fremgangsmaate ved fremstilling av nitrogen.
MX9102166A (es) Procedimiento de fabricacion de dovelas prefabricadas
NO894583D0 (no) Fremgangsmaate for fremstilling av celleplast.
NO932515D0 (no) Fremgangsmaate ved fremstilling av voerter
NO930233L (no) Fremgangsmaate ved hydratisering
NO905453L (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO923631D0 (no) Fremgangsmaate ved fremstilling av penemestere
NO920849D0 (no) Fremgangsmaate for fremstilling av l-lysin ved fermentasjon
NO914563L (no) Fremgangsmaate for fremstilling av 3h-puriner
NO915117D0 (no) Fremgangsmaate ved fremstilling av tallolje
NO930436D0 (no) Fremgangsmaate ved fremstilling av baderom
NO170491C (no) Fremgangsmaate ved fremstilling av celleplast
NO930466D0 (no) Fremgangsmaate ved fremstilling av gipsfalk
NO174960C (no) Fremgangsmåte ved fremstilling av 2-hydroksy-3-halogen-5-nitropyridiner
NO932700L (no) Fremgangsmaate ved fremstilling av etoksyetansulfonater
NO901830L (no) Fremgangsmaate ved fremstilling av polymerkuler.
NO172297C (no) Fremgangsmaate ved fremstilling av cellulosemasse
NO902987D0 (no) Fremgangsmaate ved alkylering.
NO171497C (no) Fremgangsmaate for fremstilling av syntetisk wollastonitt
NO171868C (no) Framgangsmaate for tilvirkning av tekstilstoff